During Tuesday’s Afternoon trade, Shares of First Horizon National Corp (NYSE:FHN), lost -0.28% to $15.91.
First Horizon National Corp. (FHN) will post additional materials for equity analysts in the investor relations section of its website at http://ir.fhnc.com/ recently. First Horizon anticipates to provide these materials to analysts at forthcoming meetings and conferences. The materials will be posted on the website until Sept. 30.
First Horizon National Corporation operates as the bank holding company for First Tennessee Bank National Association that provides various financial services in the United States and internationally. The company offers general banking services for consumers, businesses, financial institutions, and governments. It also provides investments, financial planning, trust, asset administration, credit card, and cash administration services.
Shares of The Medicines Company (NASDAQ:MDCO), inclined 1.27% to $31.58, during its Afternoon trading session.
The Medicines Company (MDCO) declared its financial results for the second quarter and first half of 2015.
Second-Quarter 2015 Financial Summary
Worldwide net revenue was $90.5 million for the second quarter of 2015 contrast to $183.8 million in the second quarter of 2014. Worldwide Angiomax®/Angiox® (bivalirudin) revenue was $65.6 million in the second quarter of 2015 contrast to $163.1 million in the second quarter of 2014, with revenue in the United States decreasing to $60.5 million in the second quarter of 2015 from $152.2 million in the second quarter of 2014. Recothrom®, Thrombin topical (Recombinant) sales were $15.9 million contrast to $16.3 million in the second quarter of 2014. Other products counting Cleviprex® (clevidipine), Argatroban for Injection, 50 mg per mL, Minocin® (minocycline) for injection, Orbactiv® (oritavancin) and PreveLeakTM Surgical Sealant recorded sales of $9.0 million during second quarter of 2015 contrast to $4.4 million in the second quarter of 2014. Not taking into account Angiomax, the company recorded 20% higher net revenue during the second quarter of 2015 contrast to the second quarter of 2014.
The Medicines Company provides medicines for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for use in patients undergoing percutaneous coronary intervention; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; Minocin IV, an antibiotic for the treatment of infections due to gram-negative bacteria; Orbactiv for the treatment of acute bacterial skin and skin structure infections; PreveLeak, a mechanical vascular and surgical sealant; ready-to-use formulation of Argatroban for the treatment of thrombosis; and Recothrom, a human recombinant thrombin used as an aid to hemostasis, in addition to acute care generic products for acute cardiovascular, surgery and perioperative care, and serious infectious diseases.
HD Supply Holdings Inc (NASDAQ:HDS), during its Tuesday’s Afternoon trading session decreased -0.23% to $34.72.
HD Supply, Inc, an indirect wholly-owned partner of HD Supply Holdings, Inc. (HDS) declared its intention to enter into a new Senior Secured Term Loan Facility, the proceeds of which the Company intends to use, together with cash on hand and borrowings under its existing Senior Secured Revolving Facility, to refinance its existing Senior Secured Term Loan Facility. The Company anticipates the new Senior Secured Term Loan Facility will mature in 2021 and will permit the Company to pay down certain existing indebtedness, counting using the predictable proceeds of the recently declared sale of its Power Solutions business unit to redeem all of its outstanding 11% Senior Secured Second Precedingity Notes due 2020 (the “Second Precedingity Notes”). The Company presently anticipates that the Power Solutions transaction will be accomplished in the Company’s fiscal third quarter; however, there can be no assurances that the transaction will be accomplished, as it is subject to market and other customary conditions. The Company anticipates the new Senior Secured Term Loan Facility will generally contain terms and conditions compriseent with its existing Senior Secured Term Loan Facility; however, there can be no assurance that a new facility will be accessible on terms satisfactory to the Company or that the Company will enter into any such facility.
HD Supply Holdings, Inc. operates as an industrial distributor in North America. The company’s Facilities Maintenance segment offers electrical and lighting items, plumbing, appliances, janitorial supplies, hardware, kitchen and bath cabinets, window coverings, textiles and guest amenities, healthcare maintenance, and water and wastewater treatment products, in addition to heating, ventilating, and air conditioning products.
Finally, McKesson Corporation (NYSE:MCK), decreased -0.81%, to $214.54.
The Board of Directors of McKesson Corporation (MCK) declared a regular dividend of twenty-eight cents per share on Common Stock, a four cent enhance from the preceding quarter. The dividend will be payable on October 1, 2015, to stockholders of record on September 1, 2015.
McKesson Corporation delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.